Introduction
Spinocerebellar ataxia type 8 (SCA8) (MIM 608768) is a dominantly inherited ataxia typically occurring in adulthood, with onset of the disease that may range from age 1 to 65 years [1] [2] [3] [4] [5] [6] . Common initial symptoms are scanning dysarthria with a characteristic drawn-out slowness of speech and gait instability. Some individuals present with nystagmus, dysmetric saccades and, occasionally ophthalmoplegia. Hyperreflexia and extensor plantar responses are present in some severely affected individuals. Life span is typically not shortened.
SCA8 is caused by repeat expansions initially thought to involve a non-coding CTG tract in the ATXN8OS geneformerly known as SCA8 (MIM 603680)-an untranslated antisense transcript partially overlapping the Kelch-like 1 gene (KLHL1) (MIM 605332) [7] . The CTG repeat was later found to be transcribed also in the opposite direction as (CAG) n repeat in the ATXN8 gene, encoding a nearly pure polyglutamine protein [8] .
An RNA toxic effect of the CUG expanded repeats has been suggested, together with the possibility of non-ATG translation (RAN translation) which occurs across long, hairpin-forming repeats and results in the accumulation of potentially toxic SCA8 polyalanine [9, 10] .
The (CTG.CAG) n repeat length most often associated with ataxia ranges from 80 to 250. However, repeats from 71 to more than 1300 have been occasionally found in individuals with ataxia. The disease is characterized by a reduced penetrance most often with alleles of fewer than 100 repeats.
We report two unrelated families with genomic deletions completely overlapping ATXN8OS gene and great part of KLHL1 gene. These deletions were present in a healthy parent in both families. A total of four subjects with ATXN8OS/ KLHL1 genes deletion could be studied and did not show any cerebellar symptoms or MRI changes in cerebellum.
Materials and Methods

Patients
Probands were identified during diagnostic array-CGH exams performed at the Medical Genetics Unit of the BCittà della salute e della Scienza di Torino^University Hospital and Hunter Genetics, Waratah, New South Wales, Australia.
The proband of family 1 (Decipher code: DGT283337) had an initial diagnosis of intellectual disability. She had normal karyotype and FMR1 expansion. Proband of family 2 (Decipher code: DGT278559) presented with speech delay only. He had normal FMR1 expansion. Both patients had normal urine metabolic screen, and purine and pyrimidine metabolites.
Array-CGH
Genomic DNA was extracted from peripheral blood cells using standard procedures (Qiagen, Mannheim, Germany). Array-CGH was performed on probands of both families using an 8 × 60 k whole-genome oligonucleotide array (Agilent Technologies, Santa Clara, California, USA) or the Cytochip ISCA 8×60 k array (Bluegnome) as per manufacturer's instructions. Data were analyzed with Agilent CGH analytics software (ver.4.0.81) or Bluemulti v2.4 software. Reference human genomic DNA was GRCh37/hg19.
Deletions were verified in proband of family 1 using realtime quantitative PCR (conditions available upon request). Deletion was confirmed in family 2 using FISH probes.
Clinical and Magnetic Resonance Imaging (MRI)
Routine neurological exams were performed on the probands and the parent carrying the deletion. Magnetic resonance Imaging (MRI) was performed using a 1.5 Tesla apparatus with T1, T2, and FLAIR sequences acquisition.
Results
Family 1. Phenotype
Case DGT283337 (Fig. 1) was the third daughter of healthy non-consanguineous parents; her siblings were healthy with normal intellectual abilities. Family history was unremarkable. The patient was referred for genetic assessment at 10 years of age for problems in speech and sentence structure. She was born via a normal delivery at 32 weeks of gestation after an uneventful pregnancy. Her birth weight was 3580 g (90-97th centile, according to the Italian growth curves), birth length was 53 cm (90-97th centile), and her head circumference was not reported. She had a normal review of systems. She walked without any assistance at 17 months. Lallation began at 8 months of age. Speech difficulties were reported at about 4 years and improved after therapy.
On neuropsychiatric evaluation, short attention span was noted; no motor abnormalities or other neurological signs were reported. Cognitive evaluation (WISC-III scale) demonstrated a mild intellectual deficit (IQ: 62; verbal IQ: 54; performance IQ: 79). Brain MRI (Fig. 2a-d) , eye examination, abdomen and heart ultrasounds were normal.
Her growth parameters at 9 years were between 50 and 75th percentile (height: 137 cm; weight: 33 kg; head circumference: 55 cm). She did not have a significant dysmorphism.
Her father who is now 59 years old was the only child of non-consanguineous parents. He has reported subjective sensation of instability of posture in last few years, but his neurological examination was normal. He underwent a neurological examination-including assessment through the International Cooperative Ataxia Rating Scale (ICARS)-and it revealed no abnormal gait or dysarthria, normal muscle tone and strength, coordination, sensitivity, reflexes, and cranial nerve function (in particular, oculomotor dysfunction and nystagmus have been excluded). Brain MRI showed several areas of gliosis in the frontal white matter; no cerebellar alterations were reported (Fig. 2e-h ). Auditory evoked potentials were normal; cognitive evaluation demonstrated a short attention span.
Molecular Data and Databases Mining
Array-CGH analysis revealed two paternally inherited rearrangements in the proband: a 4-Mb duplication at 8q13.33q21.11 and an 800-kb deletion at 13q21.33 (Fig. 1a,  b) . The 8q duplication was also transmitted to proband's one brother who is healthy and with an above average intelligence. The 13q deletion was absent in proband's siblings (Fig. 1a) .
The 8q duplication spans from 72,340,784 (first duplicated probe) to 76,149,340 (last duplicated probe) (GRCh37/hg19).
The 13q deletion spans from 70,370,848 (first deleted probe) to 71,062,600 (last deleted probe) (GRCh37/hg19). In this deleted region part of KLHL1 and the entire ATXOS8 genes were involved.
A search for copy number variations (CNVs) in the 8q and 13q regions surrounding the KLHL1 and ATXN8OS genes was performed in Decipher (https://decipher.sanger.ac.uk), ISCA (http://www.iscaconsortium.org), and Database of Genomic Variants (DGV; http://dgv.tcag.ca/dgv/app/home) databases.
Several duplications/deletions overlapped our 8q duplication: all were large rearrangements associated with complex phenotypes (whenever described); only two larger duplications are reported in DGV database.
Fourteen rearrangements reported in Decipher (V.7.0) overlapped the 13q21.33 deleted region: four duplications and ten deletions; most cases were large rearrangements between 1 and 20 Mb, in size with the exception of case DGT278559 described below. Several CNVs are reported, all smaller than ours.
Family 2. Phenotype and Molecular Data
Case DGT278559 was a 4-year-old boy, came to clinic for an assessment for mild expressive language delay and difficulties in articulation. His parents reported a normal prenatal and birth history, and normal growth and motor milestones acquisition. His general health has also been satisfactory. Speech improved significantly after 1 year of therapy. His height was 114.5 cm (>97th centile), weight was 20.5 kg (97th centile), and his head circumference was 52.1 cm (50-98th centile). He did not have significant dysmorphic features or major/minor malformations. His cognitive evaluation was reported to be normal. He never underwent a brain MRI. His both siblings were healthy. The 13q deletion was inherited On the X-axis, the log ratio is reported (log 2 intensity of (Cy5 fluorochrome/Cy3 fluorochrome)). Expected values are from −0.7 to −1 for a deletion (green dots), 0 for normal (black dots), and +0.5 to +1 for a duplication (red dots). Array nomenclature is reported below aCGH panels. c Detail of the region involved the two rearrangements with cytogenetic bands and gene names (Database of Genomics variants) [12] . Below, red bars indicate the two genomic deletions at chromosome 13q (patients DGT283337, DGT278559) (Decipher database) [13] . In both cases, ATXN8OS and KLHL1 are the only genes disrupted in the deleted region from his mother who did not have speech problems. She had above average intelligence. She had no sign of neurological involvement and never had a brain MRI.
Array-CGH in the proband showed a maternally inherited 357 kb deletion at 13q21.33 (Fig. 1) . The 13q deletion spanned from 70,486,026 to 70,843,210 (GRCh37/hg19). In this region part of KLHL1 and the entire ATXOS8 genes were involved.
Discussion
SCA8 is a genetically complex autosomal dominant cerebellar ataxia with incomplete penetrance and variable expressivity. A mouse model, with SCA8 BAC-expansion developed a progressive neurological phenotype, demonstrating the pathogenicity of the (CTG.CAG) n expansion [8] . However, the role of the (CTG.CAG) n repeat in the disease remained unclear. Mice heterozygous or homozygous for the Klhl1 deletion showed significant gait abnormalities, progressive loss of motor coordination, and Purkinje cell dendritic deficits [7] . These data suggested that loss of proper expression from even a single KLHL1 allele would be sufficient to cause ataxia in humans, and that pathogenic SCA8 expansions may cause the disease through a loss of KLHL1 activity in Purkinje cells.
We report two families with a similar genomic deletion in heterozygous state involving only ATXN8OS and KLHL1 genes. In both cases, the deletion segregated from an unaffected parent.
Proband of family 1 (III.3) arrived at our observation for a mild cognitive impairment. She showed two different genomic unbalances, a large duplication of 4 Mb on chromosome 8 and a deletion of 700 kb on chromosome 13. These chromosomal changes were paternally inherited and not reported in the literature. Her father did not show any pathological sign both on clinical neurologic examination and brain MRI. The 8q duplication involves at least 23 genes, none of which is associated with a dominantly inherited disease. Decipher V7.0 haploinsufficiency index suggests that three genes are dosage sensitive (EYA1, PI15, ZFHX4). We studied proband's siblings and showed that the duplication is shared by her unaffected brother (III.2). His medical history did not reveal any sign or symptom of neurologic disease, and he had normal intelligence. This strongly suggests that this rearrangement is unlikely to be associated to a pathological phenotype, even if it is a large (~4 Mb) and gene rich.
The deletion on chromosome 13 drew our attention because it contained the SCA8 region. However, no sign of c e r e b e l l a r i n v o l v e m e n t , b o t h c l i n i c a l l y a n d neuroradiologically, was present either in the father (age 59 years) or his daughter (age 9 years). Paternal grandparents were also reported healthy. Also in proband of family 2, affected by mild speech delay, the deletion involving only KLHL1 and ATXN8OS genes is inherited from a healthy mother, who did not have any neurological impairment.
Although limited to two small families, our data suggest that KLHL1/ATX8OS deletion in heterozygosis is unlikely to be associated with ataxia/cerebellar involvement. We hypothesize that SCA8 expansion is not merely causing a simple loss of function of KLHL1, contrary to what was suggested by the knockout mouse model [11] . Other pathogenic mechanisms (toxic effect of expanded (CUG) n tract at RNA level, toxic effect of the CAG-encoded polyglutamine, or potentially toxic polyalanine derived from RAN translation) may have a primary role in the disease even in combined effects [10] .
On the other hand, we cannot exclude the possibility that ATXN8OS or KLHL1 haploinsufficiency may have a role in brain development or contribute to speech/articulation problems or neuropsychiatric symptoms other than cerebellar/ataxia. This may be related to the mild intellectual disability and short attention span, respectively, in proband of family 1 and her father. Also speech difficulties, reported in both probands may possibly be related to functional alterations of KLHL1/ ATX8OS .
Our findings, suggest further studies are needed to clarify the effect of KLHL1/ATX8OS deletion in humans.
